183 related articles for article (PubMed ID: 19450982)
1. Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids.
Magesh S; Savita V; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
Bioorg Med Chem; 2009 Jul; 17(13):4595-603. PubMed ID: 19450982
[TBL] [Abstract][Full Text] [Related]
2. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors.
Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M
J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
[TBL] [Abstract][Full Text] [Related]
5. A strategy for theoretical binding constant, Ki, calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuraminidase.
Jedrzejas MJ; Singh S; Brouillette WJ; Air GM; Luo M
Proteins; 1995 Oct; 23(2):264-77. PubMed ID: 8592707
[TBL] [Abstract][Full Text] [Related]
6. Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies.
Li Y; Cao H; Yu H; Chen Y; Lau K; Qu J; Thon V; Sugiarto G; Chen X
Mol Biosyst; 2011 Apr; 7(4):1060-72. PubMed ID: 21206954
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.
Atigadda VR; Brouillette WJ; Duarte F; Ali SM; Babu YS; Bantia S; Chand P; Chu N; Montgomery JA; Walsh DA; Sudbeck EA; Finley J; Luo M; Air GM; Laver GW
J Med Chem; 1999 Jul; 42(13):2332-43. PubMed ID: 10395473
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors.
Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
Bioorg Med Chem; 2008 Apr; 16(7):3839-47. PubMed ID: 18304821
[TBL] [Abstract][Full Text] [Related]
9. Modelling, synthesis and biological evaluation of novel glucuronide-based probes of Vibrio cholerae sialidase.
Mann MC; Thomson RJ; Dyason JC; McAtamney S; von Itzstein M
Bioorg Med Chem; 2006 Mar; 14(5):1518-37. PubMed ID: 16275104
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages.
Stamatos NM; Liang F; Nan X; Landry K; Cross AS; Wang LX; Pshezhetsky AV
FEBS J; 2005 May; 272(10):2545-56. PubMed ID: 15885103
[TBL] [Abstract][Full Text] [Related]
11. Structural studies on the Pseudomonas aeruginosa sialidase-like enzyme PA2794 suggest substrate and mechanistic variations.
Xu G; Ryan C; Kiefel MJ; Wilson JC; Taylor GL
J Mol Biol; 2009 Feb; 386(3):828-40. PubMed ID: 19166860
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase.
Chand P; Kotian PL; Morris PE; Bantia S; Walsh DA; Babu YS
Bioorg Med Chem; 2005 Apr; 13(7):2665-78. PubMed ID: 15755666
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis and alpha-glucosidase inhibitory activity of N-(1,5-diaryl-3-pentone-1-yl)-4-aminobenzoic acid].
Xu J; Yan JF; Fan L; Song XL; Tang XM; Yang DC
Yao Xue Xue Bao; 2009 Jan; 44(1):48-55. PubMed ID: 19350821
[TBL] [Abstract][Full Text] [Related]
14. Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase.
Haselhorst T; Wilson JC; Thomson RJ; McAtamney S; Menting JG; Coppel RL; von Itzstein M
Proteins; 2004 Aug; 56(2):346-53. PubMed ID: 15211517
[TBL] [Abstract][Full Text] [Related]
15. Structure-based discovery of human L-xylulose reductase inhibitors from database screening and molecular docking.
Carbone V; Ishikura S; Hara A; El-Kabbani O
Bioorg Med Chem; 2005 Jan; 13(2):301-12. PubMed ID: 15598553
[TBL] [Abstract][Full Text] [Related]
16. Molecular insight into substrate recognition by human cytosolic sialidase NEU2.
Mozzi A; Mazzacuva P; Zampella G; Forcella ME; Fusi PA; Monti E
Proteins; 2012 Apr; 80(4):1123-32. PubMed ID: 22228546
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects and specificity of synthetic sialyldendrimers toward recombinant human cytosolic sialidase 2 (NEU2).
Rahman MM; Kitao S; Tsuji D; Suzuki K; Sakamoto J; Matsuoka K; Matsuzawa F; Aikawa S; Itoh K
Glycobiology; 2013 Apr; 23(4):495-504. PubMed ID: 23363739
[TBL] [Abstract][Full Text] [Related]
18. Sialidase substrate specificity studies using chemoenzymatically synthesized sialosides containing C5-modified sialic acids.
Cao H; Li Y; Lau K; Muthana S; Yu H; Cheng J; Chokhawala HA; Sugiarto G; Zhang L; Chen X
Org Biomol Chem; 2009 Dec; 7(24):5137-45. PubMed ID: 20024109
[TBL] [Abstract][Full Text] [Related]
19. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Sato K; Kitani S; Suzuki T; Maki N; Suzuki Y; Sato M
Bioorg Med Chem; 2006 Dec; 14(23):7893-7. PubMed ID: 16908163
[TBL] [Abstract][Full Text] [Related]
20. 2beta,3beta-Difluorosialic acid derivatives structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Kitani S; Sato K; Suzuki T; Hosokawa C; Suzuki Y; Tanaka K; Sato M
Carbohydr Res; 2004 May; 339(7):1367-72. PubMed ID: 15113676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
